Numerous studies have demonstrated that WDHD1 can affect the growth of esophageal cancer by regulating the PI3K/AKT pathway during the cell cycle, WDHD1 in nasopharyngeal cancer, and ITGAV in the management of the NPC cell cycle. Here, ITGAV is linked to esophageal cancer.